About this trial
The purpose of this study is to assess if the application of Mastisol, a liquid adhesive, improves outcomes during bilateral clubfoot casting and reduces complications and development of complex clubfoot for the duration of their casting and up to 5 years follow-up.
Eligibility criteria
Qualifiers
Patients with bilateral clubfeet
Starting standard of care treatment with the Ponseti method between 0-12 weeks of age
For patients born pre-maturely their eligibility age will be based on a corrected gestational age
Patients for whom at least one parent/guardian is able to converse, read, and write in English
Disqualifiers
Patients who do not have bilateral clubfoot
Patients who are starting treatment for clubfoot after 12 weeks of age
Patients whose parents/guardians are unable to converse, read, and write in English
Patients whose parents/guardian do not provide or are not able to provide informed consent
Trial design
Treatments tested in this trial
- Mastisol